Pentoxifylline

Pentoxifylline
Product Description

Pentoxifylline
Form I

> Very long production experience
> Tailor made PSD

CEP, 
US DMF, 
CHINESE


This product is not offered for sale or made available in countries where it is subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).

DISCLAIMER

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).

Products protected by patents in force in Poland are developed solely for the purpose of Regulatory Submissions.

Read more Show less

Polpharma S.A.

  • PL
  • 2015
    On CPHI since
  • 4
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    6493-05-6
  • Details
    Pentoxifylline
    Form I

    > Very long production experience
    > Tailor made PSD

    CEP, US DMF, CHINESE

    This product is not offered for sale or made available in countries where it is subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).
    DISCLAIMER

    Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).

    Products protected by patents in force in Poland are developed solely for the purpose of Regulatory Submissions.

  • Selling Points
    ✔️ HP API (OEL up to 10 ng/m3)
    ✔️ EU manufacturing site
    ✔️ US FDA-approved
    ✔️ 70 years of experience in small molecules
    ✔️ cGMP manufacturing
    ✔️ Highest quality standards
    ✔️ Research, Development, and Commercial Manufacturing
    ✔️ World-class regulatory support
    ✔️ Smooth and transparent cooperation
  • Supplied from
    Poland
  • Measured In
    gram; kilogram
More specifications Fewer specifications
Sales Markets
Show more Show less

Polpharma S.A.

  • PL
  • 2015
    On CPHI since
  • 4
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
View company profile

More Products from Polpharma S.A. (34)

  • Clopamide

    Product Clopamide

    Therapeutic Area: Cardiovascular systemEU DMF available Indication: Clopamide is indicated for the treatment of oedema, hypertension. It is formulated as tablet for oral administration. It is categorised as a thiazide like drug and works in similar way as the thiazide diuretics. It acts at the proximal c...
  • Etodolac

    Product Etodolac

    Therapeutic Area: Musculo-skeletal systemEU DMF availableUS DMF no. 11405 availableJapanese DMF availableCEP available Indication: Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used for the management of mild to moderate pain, fever, and inflammation.
  • Tadalafil

    Product Tadalafil

    Therapeutic area: genito-urinary system & sex hormones EU DMF available US DMF : 24590 CEP available
  • Ticagrelor

    Product Ticagrelor

    Ticagrelor 

    form II 

    Own process patent to free from nitrosamines 

    CEP, 
    US DMF, 
    EU DMF,  
    Korean DMF, 
    Canadian DMF, 
    Cadifa

    DISCLAIMER

    Products protected b...
  • Hydrochlorothiazide

    Product Hydrochlorothiazide

    Hydrochlorothiazide

    Therapeutic Area: Cardiovascular system • EU DMF available • US DMF no. 17599 available • Japanese DMF available  • CEP available  
    DISCLAIMER

    Products protected by valid patents are not offered for sale in countries where the sale of ...
  • Alendronate sodium

    Product Alendronate sodium

    Alendronate Sodium
    Trihydrate

    > No risk of presence of nitrosamines
    > Long experience with commercial manufacturing
    > In-house production of the whole product family (Risedronate, Alendronate, Ibandronate)

    CEP, 
    US D...
  • Dapagliflozin

    Product Dapagliflozin

    Dapagliflozin
    amorphous & propanediol

    > Cryogenic process
    > Green Chemistry

    EU DMF
    US DMF
    Korean DMF
    Canadian DMF 
    DISCLAIMER

    Products protected by valid patents are not offer...
  • Enzaluthamide

    Product Enzaluthamide

    Enzalutamide 
    Anhydrous form R1 

    CAS No: 915087-33-1
    DISCLAIMER

    Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. It is within the buyer’s respon...
  • Palbociclib

    Product Palbociclib

    Palbocyclib

    CRYSTAL FORM A
    US DMF pending

    DISCLAIMER

    Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. It is within the buyer’s responsibility and liab...
  • Apixaban

    Product Apixaban

    Apixaban

    Polymorphic form N-1

    > No risk of nitrosamines > Eco friendly process
    > PSD flexibility via micronization

    EU DMF, 
    US DMF, 
    KOREAN DMF
    DISCLAIMER

    Products protected by va...
  • Empagliflozin

    Product Empagliflozin

    Empagliflozin

    CRYSTALLINE ANHYDROUS

    > Cryogenic process
    > Green chemistry

    EU DMF, 
    US DMF, 
    CHINESE DMF, 
    KOREAN DMF

    DISCLAIMER

    Products protected by valid patents...
  • Baclofen

    Product Baclofen

    Baclofen
    FORM B

    Own innovative process

    Global market leader
    CEP, US 
    DMF, 
    JAPANESE DMF, 
    KOREAN DMF, 
    CANADIAN DMF

    DISCLAIMER

    Products protected by valid patents are not offered for s...
show all 34 other products

Polpharma S.A. resources (2)

  • CPHI Barcelona 2023: Tackling the Pharma Talent Precipice – Part 2

    News CPHI Barcelona 2023: Tackling the Pharma Talent Precipice – Part 2

    This year at CPHI Barcelona (24–26 October, 2023) we sat down with C-suite executives and HR professionals to discuss the looming talent crisis in the pharmaceutical industry. With hybrid working persisting post-pandemic and a growing skills gap, how can the pharmaceutical supply chain adjust to a changing labour force? 
    15 Nov 2023
  • API Product List 2024

    Brochure API Product List 2024

    We manufacture our products by following our customers' and health authorities' most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements of EDQM (CEP), ICH (EuDMF, CTD), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.